*West Paraiso1, Jesus Garcia-Chica2,3,4, Xavier Ariza3,5, Sebastian Zagmutt2, Shigeto Fukushima1, Jordi Garcia3,5, Yuki Mochida1, Dolors Serra4,5, Laura Herrero4,5, Hiroaki Kinoh1, Nuria Casals2,5, Kazunori Kataoka1,6, Rosalia Rodríguez-Rodríguez2, Sabina Quader1
(1. Innovation Center of Nanomedicine, Kawasaki Institute of Industrial Promotion (Japan), 2. Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya (Spain), 3. Faculty of Chemistry, Universitat de Barcelona (Spain), 4. School of Pharmacy and Food Sciences, Universitat de Barcelona (Spain), 5. Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III (Spain), 6. Institute for Future Initiatives, The University of Tokyo (Japan))
Keywords:nanomedicine, micelles, drug delivery, obesity, cancer